The treatment goal in Crohns disease is clinical remission, not complete mu
cosal healing. The incidence of mucosal inflammation in Crohns disease pati
ents in clinical remission is not known. Whole gut lavage is an objective m
ethod of assessing mucosal inflammation. We aimed to assess levels of mucos
al inflammatory activity in a group of patients with clinically inactive Cr
ohns disease. We prospectively assessed 30 patients with inactive Crohn dis
ease and 28 controls. Inactive disease was defined as Crohns disease activi
ty index of less than 150. All underwent whole put lavage, with analysis of
whole gut lavage fluid IgG, haemoglobin, interleukin-1 beta interleukin-8
and granulocyte elastase. Serum inflammatory parameters were collected for
comparison.
Of the 30 patients with Crohns disease, 10 (33%) had an abnormal immunoglob
ulin G, 21 (70%) had an elevated interleukin-Ig 20 (66%,) interleukin-8 and
10 (33%) granulocyte elastase in the whole gut lavage fluid. 58% of patien
ts had either 1 or 2 abnormal results. In contrast only 10% had 1 or 2 abno
rmal serum results. Few abnormalities were present in lavage fluid or serum
of the control population. We concluded that ongoing mucosal inflammation
is detectable in whole gut lavage fluid of up to 2/3 of Crohns disease pati
ents in clinical remission.